Poll
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
What urologists can expect in Q3 of 2025
Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
Adjuvant pembrolizumab continues to show DFS, OS benefits for ccRCC at 5-year assessment
Subcutaneous nivolumab approved in EU, Canada for solid tumors
FDA grants breakthrough device designation for ArteraAI Prostate tool
Data supports combination intravesical chemotherapy for high-risk NMIBC
EMBARK: Significant OS gains seen with enzalutamide plus leuprolide in nmHSPC
FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC